Publication Name	World Journal of Hepatology
Manuscript ID	23472
Country	Italy

Received	2015-11-24 08:42
Peer-Review Started	2015-11-25 11:36
To Make the First Decision	2015-12-28 12:10
Return for Revision	2015-12-28 15:58
Revised	2016-02-09 19:50
Second Decision	2016-03-14 08:50
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2016-03-23 16:53
Articles in Press	2016-03-23 16:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-04-14 09:59
Publish the Manuscript Online	2016-04-19 14:32

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Minireviews
Article Title	Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women?
Manuscript Source	Unsolicited Manuscript
All Author List	Anna Maria Spera, Tarek Kamal Eldin, Grazia Tosone and Raffaele Orlando
Funding Agency and Grant Number
Corresponding Author	Anna Maria Spera, MD, Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Via Sergio Pansini 5, 80131 Napoli, Italy. annamariaspera@hotmail.it
Key Words	Hepatitis C virus infection; Breastfeeding woman; Antiviral therapy; Pregnancy category; Direct-acting antivirals
Core Tip	Until recently, the only drugs available for the treatment of hepatitis C virus infection had a well-documented teratogenic effect limiting their use in child-bearing women. Recently, new generation drugs, designated the direct-acting antivirals have been app-roved. There are no studies available describing their effects on pregnant and lactating women. We here will try to analyze their pharmacokinetic properties and data from animal studies to try to predict their potential use pregnancy.
Publish Date	2016-04-19 14:32
Citation	Spera AM, Kamal Eldin T, Tosone G, Orlando R. Antiviral therapy for hepatitis C: Has anything changed for pregnant/lactating women? World J Hepatol 2016; 8(12): 557-565
URL	http://www.wjgnet.com/1948-5182/full/v8/i12/557.htm
DOI	http://dx.doi.org/10.4254/wjh.v8.i12.557

Full Article (PDF)	WJH-8-557.pdf
Full Article (Word)	WJH-8-557.doc
Manuscript File	23472-Review.docx
Answering Reviewers	23472-Answering reviewers.pdf
Audio Core Tip	23472-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	23472-Conflict-of-interest statement.pdf
Copyright License Agreement	23472-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	23472-Language certificate.pdf
Peer-review Report	23472-Peer-review(s).pdf
Scientific Misconduct Check	23472-Scientific misconduct check.pdf
Scientific Editor Work List	23472-Scientific editor work list.pdf